Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study

dc.contributor.author	Kaya, Handan
dc.contributor.author	Yazici, Hulya
dc.contributor.author	Iyikesici, Salih
dc.contributor.author	Serdar, Turhal N.
dc.contributor.author	Guney, Nese
dc.contributor.author	Basaran, Gul Atalay
dc.contributor.author	Saip, Pinar
dc.date.accessioned	2021-03-05T16:31:17Z
dc.date.available	2021-03-05T16:31:17Z
dc.identifier.citation	Basaran G. A. , Guney N., Saip P., Iyikesici S., Kaya H., Yazici H., Serdar T. N. , "Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study", 31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.90-91
dc.identifier.other	vv_1032021
dc.identifier.other	av_c10d63d0-7726-4a43-9dd9-370dd5c3b09d
dc.identifier.uri	http://hdl.handle.net/20.500.12627/128129
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	17
dc.contributor.firstauthorID	131577

Files in this item

Files	Size	Format	View
There are no files associated with this item.